﻿<rss version="2.0"><channel><title>Primary Psychiatry - Current Issue</title><link>http://www.primarypsychiatry.com/</link><description>The Largest Peer Reviewed Phychiatric Journal in the Nation</description><ttl>60</ttl><item><title>The Importance of Expertise</title><description>It is a point I have made before, but the content of this issue of Primary Psychiatry reminds me of how important it is for those who diagnose and treat patients with mental disorders know those disorders and their treatments well.
</description><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2822</link><author>Norman Sussman, MD</author><pubDate>Wed, 1 Sep 2010 09:18:13 -05</pubDate></item><item><title>Letter to the Editor: Bipolar Disorder in Children and Adolescents – In Session with Kiki Chang, MD</title><description>It is with dismay that I read Kiki Chang, MD’s response to the argument that the increase in diagnosis of bipolar disorder in children and adolescents is because there are now drugs approved and promoted for that diagnosis.</description><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2823</link><author>Letter: Roger Z. Samuel, MD, FAPA; Response: Kiki Chang, MD</author><pubDate>Wed, 1 Sep 2010 09:40:14 -05</pubDate></item><item><title>How Neuroscience Explains Age-related Changes in Cognition: Implications for the Early Diagnosis of Dementia</title><description>Criteria for Alzheimer’s disease and preclinical dementia have been proposed recently, which include potential biomarkers of the illness.</description><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2824</link><author>Gary J. Kennedy, MD</author><pubDate>Wed, 1 Sep 2010 09:53:37 -05</pubDate></item><item><title>In Session with Daphne Holt, MD, PhD: Brain Imaging Work and Its Potential Practical Applications to Treat Mental Disease</title><description>Dr. Holt is Assistant Professor at Harvard Medical School as well as Associate Psychiatrist and Associate Director of the First Episode and Early Psychosis Program at Massachusetts General Hospital in Boston. In her research, Dr. Holt applies neuroimaging methods, such as functional and structural magnetic resonance imaging and electroencephalography, to the study of the neural basis of emotional function and social behavior in healthy people and patients with psychiatric disorders, particularly schizophrenia.</description><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2825</link><author>Daphne Holt, MD, PhD, interviewed by Norman Sussman, MD</author><pubDate>Wed, 1 Sep 2010 10:17:51 -05</pubDate></item><item><title>Smoking Quetiapine: A “Maq Ball”?</title><description>Quetiapine abuse has been a cause for increased concern among clinicians. Several reports have highlighted this in the past.</description><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2826</link><author>Arun Haridas, MD, MRCPsych, Donald Kushon, MD, Samson Gurmu, MD, and Olumide Oluwabusi, MD, MRCPsych</author><pubDate>Wed, 1 Sep 2010 10:44:57 -05</pubDate></item><item><title>Factitious Disorder Case Series with Variations of Psychological and Physical Symptoms</title><description>In the clinical setting, factitious disorder is often mistaken for malingering or somatoform disorders. Three cases of factitious disorder with physical, psychological, and combined symptoms are reported.</description><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2827</link><author>Waguih William IsHak, MD, Ernest Rasyidi, MD, Tammy Saah, MD, Monisha Vasa, MD, Amir Ettekal, MD, and Alexander Fan, MD</author><pubDate>Wed, 1 Sep 2010 10:54:53 -05</pubDate></item><item><title>Comparative Efficacy and Safety of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended Release in Adults With Attention-Deficit/Hyperactivity Disorder</title><description>Psychostimulants are pharmacotherapeutic mainstays for children and adults with attention-deficit/hyperactivity disorder.</description><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2828</link><author>Robert Lasser, MD, Bryan Dirks, MD, Ben Adeyi, MS, and Thomas Babcock, DO</author><pubDate>Wed, 1 Sep 2010 11:17:19 -05</pubDate></item><item><title>Safety of Varenicline in Patients with 
Mental Illness</title><description>This article reviews literature regarding safety of smoking-cessation aid varenicline for patients with mental illness.</description><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2829</link><author>Raymond A. Lorenz, PharmD, BCPP, Heather P. Whitley, PharmD, BCPS, CDE, and Emily K. McCoy, PharmD</author><pubDate>Wed, 1 Sep 2010 11:39:26 -05</pubDate></item><item><title>Psychiatric Dispatches: News from the Alzheimer’s Association International Conference on Alzheimer’s Disease 2010: September 2010</title><description /><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2830</link><author /><pubDate>Wed, 1 Sep 2010 11:45:42 -05</pubDate></item><item><title>Letter to the Editor: Aripiprazole for Depression:
A Warning</title><description>Antipsychotics all share the property of blocking dopamine receptors in the brain.</description><link>http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2844</link><author>Joseph H. Friedman, MD, and Daniel Tarsy, MD</author><pubDate>Wed, 22 Sep 2010 11:23:52 -05</pubDate></item></channel></rss>